Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa

Emerging Infectious Diseases

Volumn 16, Issue 2, 2010, Pages 264-271

  Calver, Alistair D ^a   Falmer, Alecia A ^b   Murray, Megan ^c   Strauss, Odelia J ^b   Streicher, Elizabeth M ^b   Hanekom, Madelene ^b   Liversage, Thelma ^a   Masibi, Mothusi ^a   Van Helden, Paul D ^b   Warren, Robin M ^b   Victor, Thomas C ^b  

^a West Vaal Hospital   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; DELAYED DIAGNOSIS; DRUG DOSE REGIMEN; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; SCREENING TEST; SOUTH AFRICA; TUBERCULOSIS CONTROL;

EID: 76149126427     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1602.090968     Document Type: Article

References (34)

1. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug resistant tuberculosis. 1997 [cited 2008 Mar 1]. http://whqlibdoc. who.int/hq/1997/WHO-TB-96.210-(Rev.1).pdf
2. Coker RJ. Multidrug-resistant tuberculosis: public health challenges. Trop Med Int Health. 2004;9:25-40. DOI: 10.1046/j.1365-3156 .2003.01156.x
3. Weyer K. Survey of tuberculosis drug resistance, 2001-2002, Western Cape. 2001 [cited 2008 Mar 1]. http://www.sahealthinfo.org/tb/ tbdrugresistance.htm
4. Global WHO-IUTALD. Project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world (Report no. 4). 2008 [cited 2008 Apr 1]. http://www.who.int/tb/ publications/2008/drs-report4- 26feb08.pdf.
5. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep. 2006;55:301-5.
6. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-80. DOI: 10.1016/S0140-6736(06)69573-1
7. Van Rie A, Enarson D. XDR tuberculosis: an indicator of public-health negligence. Lancet. 2006;368:1554-6. DOI: 10.1016/S0140-6736(06)69575-5
8. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in Kwa-Zulu-Natal, South Africa. Clin Infect Dis. 2007;45:1409-14. DOI: 10.1086/522987
9. Cox HS, Sibilia K, Feuerriegel S, Kalon S, Polonsky J, Khamraev AK, et al. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis. N Engl J Med. 2008;359:2398-400. DOI: 10.1056/NEJMc0805644
10. Stop TB partnership. Stop TB working group on DOTS-Plus for MDR-TB. 2006 [cited 2008 Mar 1]. http://www.stoptb.org/wg/dots-plus
11. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008;12:99-104.
12. Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, van Helden PD, et al. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis. 2006;10:802-7.
13. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
14. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
15. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001;39:3563-71. DOI: 10.1128/JCM.39.10.3563-3571.2001
16. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8:97-111.
17. van Rie A, Warren R, Richardson M, Gie RP, Enarson DA, Beyers N, et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet. 2000;356:22-5. DOI: 10.1016/S0140-6736-(00)02429-6
18. Swofford DL. PAUP: Phylogenetic analysis using parsimony. Champaign (IL): Illinois Natural History Survey; 1991.
19. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-9. DOI: 10.1056/NEJM199406163302402
20. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537-44. DOI: 10.1038/31159
21. van Rie A, Warren RM, Beyers N, Gie RP, Classen CN, Richardson M, et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis. 1999;180:1608-15. DOI: 10.1086/315054
22. Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis. 2007;11:195-201.
23. Li X, Zhang Y, Shen X, Shen G, Gui X, Sun B, et al. Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis. 2007;195:864-9. DOI: 10.1086/511985
24. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430-5. DOI: 10.1164/rccm.200409-1200OC
25. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus after tuberculosis infection. Am J Respir Crit Care Med. 1995;151:129-35.
26. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042-9. DOI: 10.1016/S0140-6736-(07)60284-0
27. van Helden PD, Donald PR, Victor TC, Schaaf HS, Hoal EG, Walzl G, et al. Antimicrobial resistance in tuberculosis: an international perspective. Expert Rev Anti Infect Ther. 2006;4:759-66. DOI: 10.1586/14787210.4.5.759
28. Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, Sirotkina OB, et al. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis. 2004;39:1321-8. DOI: 10.1086/425005
29. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy, G, Kewley C, et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis. 2006;10:68-73.
30. Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin Infect Dis. 2007;44:1421-7. DOI: 10.1086/517536
31. Mphahlele M, Syre H, Valvatne H, Stavrum R, Mannsaker T, Muthivhi T, et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol. 2008;46:3459-64. DOI: 10.1128/JCM.00973-08
32. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, et al. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008;47:1126-34. DOI: 10.1086/592252
33. World Health Oganization. Guidelines for the programmatic management of drug-resistant tuberculosis. Rich M, Cegielski P, Jaramillo E, Lambregts K, editors. 2006 [cited 2008 Mar 1]. http://whqlibdoc.who.int/publications/2006/ 9241546956-eng.pdf
34. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787-92. DOI: 10.1164/rccm.200709-1436OC